Xilio Therapeutics, Inc. Shares Outstanding (Cover Page)
Xilio Therapeutics, Inc. (XLO) had Shares Outstanding (Cover Page) of 5.78 million shares as of 2026-03-18, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-03-23
- 2026-03-18: Entity Common Stock, Shares Outstanding 5.78M shares.
- 2025-11-11: Entity Common Stock, Shares Outstanding 52.50M shares.
- 2025-08-08: Entity Common Stock, Shares Outstanding 51.83M shares.
- 2025-05-05: Entity Common Stock, Shares Outstanding 51.78M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-03-18 | 5.78M shares 10-K · filed 2026-03-23 |
| 2025-11-11 | 52.50M shares 10-Q · filed 2025-11-13 |
| 2025-08-08 | 51.83M shares 10-Q · filed 2025-08-14 |
| 2025-05-05 | 51.78M shares 10-Q · filed 2025-05-08 |
| 2025-03-03 | 51.77M shares 10-K · filed 2025-03-11 |
| 2024-11-01 | 43.96M shares 10-Q · filed 2024-11-07 |
| 2024-08-01 | 43.95M shares 10-Q · filed 2024-08-08 |
| 2024-05-10 | 36.91M shares 10-Q · filed 2024-05-14 |
| 2024-03-28 | 34.47M shares 10-K · filed 2024-04-01 |
| 2023-11-07 | 27.54M shares 10-Q · filed 2023-11-09 |
| 2023-08-04 | 27.54M shares 10-Q/A · filed 2023-11-09 |
| 2023-05-05 | 27.47M shares 10-Q/A · filed 2023-11-09 |
| 2023-02-24 | 27.47M shares 10-K/A · filed 2023-11-09 |
| 2022-11-04 | 27.47M shares 10-Q · filed 2022-11-09 |
| 2022-08-01 | 27.47M shares 10-Q · filed 2022-08-09 |
| 2022-05-04 | 27.47M shares 10-Q · filed 2022-05-12 |
| 2022-02-15 | 27.47M shares 10-K · filed 2022-03-01 |
| 2021-11-25 | 27.47M shares 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 |